HEPA Hepion Pharmaceuticals Inc

$HEPA SCAMMERS You’ve lived through real hardship. You’ve carried your family. You’ve seen how fragile life can be. You’ve watched people struggle with depression, addiction, loss, financial pressure. So when you see a company that contributes nothing, yet extracts money from people who are already struggling, it hits differently. It feels personal. And honestly? It should make you angry.

$HEPA - interesting movement in volume recently with today matching the earlier September spike

$HEPA Majority Stockholders have taken and approved the following actions: 1. Approved an amendment to the Company’s Certificate of Incorporation, as amended (the “Certificate of Incorporation”) to effect a reverse stock split of the Company’s Common Stock at a ratio of between 1-for-20 and 1-for-50 (the “Reverse Stock Split”), with such ratio to be determined at the sole discretion of the Board and with such Reverse Stock Split to be effected at such time and date, if at all, as determined by the Board in its sole discretion; 2. Approved an amendment to the Certificate of Incorporation to increase the number of shares of authorized Common Stock from 120,000,000 to 750,000,000; and 3. Approved an amendment to the Company’s 2023 Omnibus Equity Incentive Plan to increase the number of shares issuable thereunder from 8,000,000 to 18,000,000.

$HEPA How can the Inventor of Rencofilstat Dr Robert Foster state when he was inducted into Alberta order of excellence 2024 after he left for good reason state that Rencofilstat has significant potential to treat a number of diseases be sold for nothing with CVR's Brancaccio was working for someone and it wasn't shareholders how is he not in prison someone steals a candy bar from 7-11 and they are handcuffed everyone needs to send or keep sending complaints to SEC to show the theft that has happened.

$HEPA as per Google: Gravitas Life Sciences, LLC is a biotechnology research and development company recently acquired by Hepion Pharmaceuticals on October 9, 2026. Key Corporate History & Recent Deals • Previous Ownership: Formerly the biotech R&D arm of Canton Strategic Holdings, Inc. (NASDAQ: CNTN). • July 2026 Sale: Canton Strategic Holdings sold Gravitas Life Sciences to Gravitas Collective Corp., closing on July 17, 2026. • October 2026 Acquisition: Hepion Pharmaceuticals completed the acquisition of Gravitas Life Sciences for $2.0 million in cash plus 25 million shares (subject to a 19.99% issuance cap), alongside an additional $135,000 cash payment and a partial payoff/assumption of a note with Canton Strategic Holdings. • Leadership Impact: Sireesh Appajosyula, PharmD (former CEO of Gravitas Life Sciences) was appointed Chief Executive Officer of Hepion Pharmaceuticals effective October 9, 2026. • Pipeline: The transaction expands Hepion's immunology and inflammation pipeline.

$HEPA CVR holders need to be payed out when Rencofilstat is sold Panetta Partners is just a holder otherwise it would of made no sense for Hepion board of directors to do what they did if this doesnt playout the way it should im getting the best lawyer money can buy and they can have percentage of the buyout price

$HEPA insiders topping up. Shares+ warrants. Shares get RS, not warrants. This is how Cerrone has stolen Rencofilstat 1.5 year ago.